IP Verse

Treatment Of Phenylketonuria With Bh4

Patent No. EP3138566 (titled "Treatment Of Phenylketonuria With Bh4") was filed by Biomarin Pharmaceutical on Nov 17, 2004. The application was issued on Jan 26, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DIPHARMAOct 26, 2022ELKINGTON AND FIFE
TOBIO NOVELFARMA ILAC SAN VE TICOct 12, 2022BULUT
STADA ARZNEIMITTELOct 6, 2022HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3138566

BIOMARIN PHARMACEUTICAL
Application Number
EP16178739A
Filing Date
Nov 17, 2004
Status
Revoked
Jun 7, 2024
Publication Date
Jan 26, 2022
External Links
Slate, Register , Google Patents